Form 8-K - Current report:
SEC Accession No. 0001023024-25-000056
Filing Date
2025-05-23
Accepted
2025-05-23 07:00:14
Documents
13
Period of Report
2025-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ani-20250522.htm   iXBRL 8-K 68193
2 EX-3.1 exhibit31certificateofamen.htm EX-3.1 6845
  Complete submission text file 0001023024-25-000056.txt   198858

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20250522.xsd EX-101.SCH 1755
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20250522_lab.xml EX-101.LAB 22532
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20250522_pre.xml EX-101.PRE 13026
15 EXTRACTED XBRL INSTANCE DOCUMENT ani-20250522_htm.xml XML 2790
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 25979217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)